Bangladesh

Births taking place at setting

4.0%

BMMS 2016 [13]

9.3%

BMMS 2016 [13]

3.7%

BMMS 2016 [13]

50.2%

BMMS 2016 [13]

32.8%

BMMS 2016 [13]

Births receiving each uterotonic in status quo

Injectable oxytocin

90.2%

Health facility survey [15]

83.9%

Health facility survey [15]

11%

Health facility survey [15]

0%

Assumption

86%

Health facility survey [15]

Misoprostol

0%

Assumption

0%

Assumption

69%

Health facility survey [15] Nasreen et al. 2011 [40]

42%^{b}

Quaiyum et al. 2014 [41]

0%

Assumption

Births receiving each uterotonic in intervention scenario^{a}

Injectable oxytocin

63%

BMMS 2016 [13]

20%

BMMS 2016 [13]

0%

Assumption

0%

Assumption

86%

BMMS 2016 [13]

Misoprostol

0%

Assumption

0%

Assumption

0%

Assumption

0%

Assumption

0%

Assumption

Inhaled oxytocin

28%

Assumption

64%

Assumption

80%

Assumption

42% ^{b}

Assumption

0%

Assumption

Ethiopia

Births taking place at setting

9.5%

EmONC assessment 2016 [17]

58.4%

EmONC assessment 2016 [17]

4.5%

Sibley et al. 2014 [18]

25.5%

Sibley et al. 2014 [18]

2.1%

EmONC assessment 2016 [17]

Births receiving each uterotonic in status quo

Injectable oxytocin

81%

EmONC assessment 2016 [17]

81%

EmONC assessment 2016 [17]

0%

Assumption

0%

Assumption

81%

EmONC assessment 2016 [17]

Misoprostol

0%

Assumption

0%

Assumption

84%^{c}

Health facility survey [42]

0%

Assumption

0%

Assumption

Births receiving each uterotonic in intervention scenario^{a}

Injectable oxytocin

2%

EmONC assessment 2016 [17]

0%

Assumption

0%

Assumption

0%

Assumption

81%

EmONC assessment 2016 [17]

Misoprostol

0%

Assumption

0%

Assumption

0%

Assumption

0%

Assumption

0%

Assumption

Inhaled oxytocin

78%

Assumption

81%

Assumption

84% ^{c}

Assumption

0%

Assumption

0%

Assumption
